By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

A new study shows that blocking the IL-1β signaling pathway in the brain can halt the damaging inflammation that drives neuromyelitis optica (NMO), a severe autoimmune disease. Researchers found that using an antisense oligonucleotide (ASO) to lower IL-1β levels protected nerve cells and improved movement in mice, offering a promising new treatment approach for this condition.

Today’s Diabetes Science Briefing | May 3rd 2026, 10:10:16 am

Today’s Diabetes Science Briefing | May 3rd 2026, 10:10:16 am

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Medicine - Today’s Diabetes Science Briefing | May 3rd 2026, 10:10:16 am

Medicine

Today’s Diabetes Science Briefing | May 3rd 2026, 10:10:16 am

Last updated: May 3, 2026 8:10 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

Key Highlights

•
A new nanoparticle system delivers the drug formoterol directly to the kidneys, significantly reducing diabetic kidney disease in lab models without causing harmful effects on the heart.
Source →

•
A study analyzing the health records of over 43,000 adults aged 75 and older found that taking antihypertensives was linked to better cognitive resilience, while psychiatric conditions, Black race, and Medicaid enrollment were linked to a higher risk of cognitive decline.
Source →


Stay curious. Stay informed — with
Science Briefing.

Always double check the original article for accuracy.


Reset My Briefings

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Today’s Public Health Science Briefing | May 3rd 2026, 9:00:06 am
Next Article Today’s Diabetes Science Briefing | May 3rd 2026, 10:10:16 am
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

The Gendered Toll of Sleeplessness on the Brain

The Diagnostic Dilemma of Missing Variants in Alport Syndrome

This weeks’ Key Highlights of null science

The Long Road to Treatment: A Barrier in Addiction Care

This week’s Medicine Key Highlights

Antidepressants in Huntington’s: A surprising shield against progression

Antidepressants: A Protective Turn in Huntington’s Disease

Fenofibrate’s Dual Role: A New Look at an Old Lipid Drug

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Gastroenterology
  • Surgery
  • Energy
  • Natural Language Processing
  • Chemistry
  • Neurology
  • Engineering

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?